← Back to Search

Robotics

Robot + Active Learning Program(RT-ALPS) for Stroke

N/A
Waitlist Available
Research Sponsored by Spaulding Rehabilitation Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 10 weeks
Awards & highlights

Study Summary

This trial will study the effects of robot-assisted therapy on post-stroke patients' ability to use their affected arm in every day activities.

Eligible Conditions
  • Stroke

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 10 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 10 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from Baseline Fugl-Meyer Assessment (FMA) at 10 weeks
Change from Baseline Fugl-Meyer Assessment (FMA) at 6 weeks
Change from Baseline Motor Activity Log (MAL) Amount of Use (AOU) at 10 weeks
+3 more
Secondary outcome measures
Change from Baseline Canadian Occupational Performance Measure (COPM) at 10 weeks
Change from Baseline Canadian Occupational Performance Measure (COPM) at 6 weeks
Change from Baseline Confidence in Arm and Hand Movement (CAHM) Scale at 10 weeks
+13 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Robot + Active Learning Program(RT-ALPS)Experimental Treatment1 Intervention
Armeo & Amadeo robot-assisted intensive upper limb therapy 1 hour sessions 3x week for 6 weeks plus training in active problem solving, analysis of performance, and goal-setting focused on the transfer of acquired motor skills to daily activities in the home and community.
Group II: Robot-Assisted Therapy (RT)Active Control1 Intervention
Armeo & Amadeo robot-assisted intensive upper limb therapy 1 hour sessions 3x week for 6 weeks.

Find a Location

Who is running the clinical trial?

Spaulding Rehabilitation HospitalLead Sponsor
134 Previous Clinical Trials
11,009 Total Patients Enrolled
25 Trials studying Stroke
1,003 Patients Enrolled for Stroke
American Occupational Therapy FoundationOTHER
12 Previous Clinical Trials
357 Total Patients Enrolled
5 Trials studying Stroke
154 Patients Enrolled for Stroke
Paolo Bonato, PhDStudy ChairSpaulding Rehabilitation Hospital
22 Previous Clinical Trials
724 Total Patients Enrolled
10 Trials studying Stroke
317 Patients Enrolled for Stroke

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the principal aims of this trial?

"This trial has two main objectives to assess over a period of around 10 weeks: (1) Alterations in Fugl-Meyer Assessment scores and (2) Modifications in Confidence in Arm and Hand Movement Scale. Secondary goals include shifts from the initial Home-based Accelerometry readings, as measured by GENEActiv sensors worn for 72 hours on both wrists at each assessment point; along with changes recorded via Wolf Motor Function Test Time assessments which can take up to 2 minutes per task, scored on a 6-point scale."

Answered by AI

How many participants have been allowed to enroll in this experiment?

"Correct. According to clinicaltrials.gov, this investigation is still in search of participants and was first posted on June 6th 2019 with its most recent update taking place on May 26th 2022. This requires 15 people to be recruited from two distinct medical sites."

Answered by AI

Is this experiment presently accepting new participants?

"Affirmative, clinicaltrials.gov indicates that this study is in the process of recruiting patients. Published on June 6th 2019 and last modified on May 26th 2022, the research aims to select 15 participants from 2 different sites."

Answered by AI
~1 spots leftby Apr 2025